Brussels, 24/02/2015 (Agence Europe) - The preliminary results from a clinical trial carried out in Guinea into an anti-viral medicine, favipiravir, for treating the Ebola disease, are encouraging. The medicine tested helped to reduce mortality among certain patients in early stages of the disease. This announcement was made on Monday 23 February by the French National Institute of Health and Medical Research (INSERM), which is coordinating this EU-financed research project. The European...